Physician

Charles J Breen, M.D.

According to 2025 Medicare claims, Charles Breen, M.D. (NPI: 1437151719) practices ophthalmology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Boone, KY. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 41042-4896. Breen is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Breen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 810 traditional Medicare patients, billed 1,835 HCPCS/CPT codes, and received $202,871 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,953 prescription claims across 615 beneficiaries totaling $993,181 in drug costs, led by Xiidra (Lifitegrast). 2020 DME data shows 11 claims. Open Payments data shows 74 records totaling $2,488. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $268,114 to $993,181. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	803	1,804	$168,429
2016	941	2,158	$228,880
2017	975	2,275	$268,128
2018	997	2,393	$278,067
2019	984	2,479	$297,429
2020	855	2,129	$275,679
2021	972	2,471	$320,406
2022	881	2,049	$244,708
2023	850	2,233	$284,350
2024	810	1,835	$202,871

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	464	1,948	$268,114
2016	559	2,166	$418,304
2017	600	2,357	$475,097
2018	638	2,478	$590,593
2019	693	2,257	$769,694
2020	635	2,225	$824,457
2021	650	2,203	$891,145
2022	611	1,945	$802,745
2023	674	2,078	$928,998
2024	615	1,953	$993,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	15	15	$787
2019	28	28	$1,175
2020	11	11	$614
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92004	New patient complete exam of visual system	97	97	$83
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	590	683	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	124	134	$59
92083	Exam of visual field with extended testing	96	101	$40
92134	Imaging of retina	81	155	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xiidra	Lifitegrast	276	14,040	$312,804
Restasis	Cyclosporine	231	13,875	$284,702
Lumigan	Bimatoprost	234	12,347	$108,857
Cequa	Cyclosporine	71	3,243	$63,091
Cyclosporine	Cyclosporine	59	4,260	$50,132

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$2,488	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles J. Breen, M.D.?

Tedicare shows public-source Medicare data for Charles J. Breen, M.D. (NPI 1437151719), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles J. Breen, M.D. have ACO affiliation data?

Charles J. Breen, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Charles J. Breen, M.D.?

Charles J. Breen, M.D. is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Charles J. Breen, M.D. have Open Payments data?

Charles J. Breen, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.